All News

A study found early medical abortion at home up to 12 weeks’ gestation is as safe and effective as in-hospital care, supporting expanded access.

A study highlights rising rates of cardiovascular complications during pregnancy and underscores the need for preventive care before, during, and after birth.

Sarah Glynne, MBBS, BSc, and Jayant S. Vaidya, MD, FRCS, PhD, urge clinicians to move beyond blanket bans and support informed, patient-centered care.

New SMFM guidance outlines key recommendations for diagnosing, counseling, and managing heart failure in pregnancy and postpartum.

Jayant S. Vaidya, MD, FRCS, PhD, and Sarah Glynne, MBBS, BSc, discuss new evidence challenging the blanket ban on HRT use after breast cancer.

New research highlights an increased risk of urinary incontinence following hysterectomy, underscoring the need for long-term management strategies.

Elevated maternal sFlt-1 and sFlt-1/PlGF ratios are linked to placental abruption, highlighting potential early risk assessment in singleton pregnancies.

Children born preterm face significantly reduced odds of completing high school and university compared with full-term peers.

As public uncertainty about vaccination during pregnancy grows, experts highlight the vital role of trusted health care providers in addressing hesitancy.

A study highlights the potential of salpingectomy to reduce ovarian cancer incidence, while experts call for international collaboration.

Review some of the top stories from the Contemporary OB/GYN website over the past week and catch up on anything you may have missed.

A review found labetalol demonstrates modest benefits in reducing preeclampsia and preterm birth in hypertensive pregnancies.

On October 2, 2025, the FDA approved a generic version of mifepristone to be used in a regimen with misoprostol for abortion.

Take a quick look at everything you may have missed during the third quarter of 2025, including the latest FDA approvals, top stories, and exclusive interviews.

A survey reveals declining confidence in COVID-19 vaccination during pregnancy, with fewer adults recommending it despite scientific evidence.

A panel issued new consensus statements on hormone therapy for breast cancer survivors, highlighting when estrogen may be considered.

Take a quick look at everything you may have missed in September, including the latest FDA updates, top stories, and exclusive interviews.

A study found that menopause does not increase disability progression in women with multiple sclerosis

Rising childcare costs, limited access to daycare, and shifting generational attitudes are driving historic declines in US birth rates.

Experts discuss the future of healthcare, emphasizing innovative STI care, education, and the importance of collaboration in improving patient outcomes.

Panelists explore the future of STI screening and management, emphasizing the importance of guidelines and innovative diagnostics in women's health.

Discover how accessible STI testing and early detection enhance maternal-fetal health, reducing risks for mothers and newborns alike.

Innovations in diagnostic testing enhance patient care, empowering women with at-home options and faster access to essential health services.

Experts discuss the FDA's priority review of gepotidacin, an oral gonorrhea treatment, highlighting its potential to improve women's health and access to care.

Experts discuss updates in STI testing, congenital conditions, and best practices for pregnant women in this insightful healthcare panel.

Check out the top conferences happening in the fourth quarter of 2025.

A new study shows surgeons are more likely to adopt opportunistic salpingectomy for sterilization when their peers already use the procedure.